• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Philips' 'Boris Platform' moves in as new ultrasound architecture

Article

Technology will not replace HDI or SonosPhilips is preparing a new technology platform upon which to base future ultrasound systems. Dubbed the Boris Platform, it is not a physical system but rather a fundamental architecture that

Technology will not replace HDI or Sonos

Philips is preparing a new technology platform upon which to base future ultrasound systems. Dubbed the Boris Platform, it is not a physical system but rather a fundamental architecture that can be used to support other systems and features in the future, according to Terrence J. Sweeney, Philips vice president of corporate quality and regulatory affairs.

"We are developing capabilities-the hardware, software interfaces-not a new product, like something you would wheel down a hallway," he said. "It will evolve into products later on."

Boris will not replace either of Philips' current major product platforms, the radiology-oriented HDI or cardiology-oriented Sonos. Boris simply gives Philips an additional technology with which to advance the state of the art, according to Sweeney.

R&D engineers with a penchant for Saturday morning cartoons (e.g., moose and squirrel) apparently named the technology platform, which cleared the FDA in March (SCAN 5/14/03). Its development and the decision to submit it to the FDA were not so frivolous. The 510(k) submission, according to Sweeney, is intended to establish a technical file to which FDA reviewers can refer when evaluating future filings regarding this architecture.

"Due to the innovative nature of the Boris technology, we started working early with the FDA to assure their medical device review requirements could be met," he said. "By obtaining this first clearance, a regulatory pathway has now been established supporting the development of new ultrasound applications."

If all goes according to plan, this will have been the first of many Boris submissions, Sweeney said, with each new one offering an expanded capability.

"We plan to use this as a 510(k) platform from which to launch things," he said. "It's designed to help us get things cleared more rapidly."

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.